Abstract
In recent years, the gut microbiota and derived metabolites have emerged as relevant players in modulating several brain functions, including energy balance control1, 2–3. This form of distant communication mirrors that of metabolic hormones (for example, leptin, ghrelin), which convey information about the organism’s energy status by exerting effects on diverse brain regions, including the master homeostatic centre, the hypothalamus4. However, whether the hypothalamus is also able to influence gut microbiota composition remains enigmatic. Here we present a study designed to unravel this challenging question. To this aim, we used chemogenetics5 (to selectively activate or inhibit hypothalamic pro-opiomelanocortin or agouti-related peptide neurons) or centrally administered leptin or ghrelin to male mice. Subsequently, we conducted microbiota composition analysis throughout the gut using 16S rRNA gene sequencing. Our results showed that these brain interventions significantly changed the gut microbiota in an anatomical and short-term (2–4 h) fashion. Transcriptomic analysis indicated that these changes were associated with the reconfiguration of neuronal and synaptic pathways in the duodenum concomitant with increased sympathetic tone. Interestingly, diet-induced obesity attenuated the brain-mediated changes triggered by leptin in gut microbiota communities and sympathetic activation. Our findings reveal a previously unanticipated brain–gut axis that acutely attunes microbiota composition on fast timescales, with potential implications for meal-to-meal adjustments and systemic energy balance control.
| Originalsprache | Englisch |
|---|---|
| Zeitschrift | Nature Metabolism |
| Jahrgang | 7 |
| Ausgabenummer | 6 |
| Seiten (von - bis) | 1123-1135 |
| Seitenumfang | 13 |
| ISSN | 2522-5812 |
| DOIs | |
| Publikationsstatus | Veröffentlicht - 06.2025 |
Fördermittel
The project leading to these results received funding from \u2018la Caixa\u2019 Foundation (ID100010434) under project no. LCF/PR/HR19/52160016 (to M.C., R.N. and P.D.C.), with the support of Project 2021-SGR-01320 from the Generalitat de Catalunya, Departament de Recerca i Universitats and the CERCA Programme/Generalitat de Catalunya (to M.C.), and a European Research Council ERC-Synergy-Grant-2019-WATCH no. 810331 (to R.N. and M.S.). M.T. is a recipient of a Beatriu de Pin\u00F3s postdoctoral fellowship (2018 BP00032), funded by the Secretary of Universities and Research (Government of Catalonia), and by the Horizon 2020 programme of the European Union under a Marie Sk\u0142odowska-Curie grant no. 801370, as well as a contract funded by the Instituto de Salud Carlos III with European funds from the Recovery, Transformation, and Resilience Plan, under file code IHMC22/00039 and Funded by the European Union-Next Generation EU. I.M-I. was supported by the Miguel Servet Type II program (CPII21/00013) of the ISCIII-Madrid (Spain) and co-funded by the European Union. A.O. is the recipient of a Miguel Servet contract (no. CP19/00083) funded by the Instituto de Salud Carlos III and co-funded by the European Social Fund \u2018Investing in your future\u2019. R.H-T. is a recipient of a Ramon y Cajal contract (no. RYC2022-037070-I) from the Ministerio de Ciencia e Innovaci\u00F3n of Spain. P.D.C. is an honorary research director at the Fonds de la Recherche Scientifique/Fonds National de la Recherche Scientifique and recipient of a Fonds de la Recherche Fondamentale Strat\u00E9gique-Walloon Excellence in Life Sciences and BIO (WELBIO) technology WELBIO grant no. WELBIO-CR-2022A-02 and EOS program no. 40007505. We are indebted to the Functional Genomics Core Facility of the Institut d' Investigacions Biom\u00E8diques August Pi i Sunyer for their technical help. This work was carried out in part at the Esther Koplowitz Centre, Barcelona.
| Träger | Trägernummer |
|---|---|
| Ministerio de Ciencia e Innovación | |
| Horizon 2020 Framework Programme | |
| Universitat Internacional de Catalunya | |
| Miguel Servet Type II program | |
| Departament de Recerca i Universitats, Generalitat de Catalunya | |
| European Research Council | 810331, 2018 BP00032 |
| European Social Fund Plus | RYC2022-037070-I |
| H2020 Marie Skłodowska-Curie Actions | 801370 |
| Instituto de Salud Carlos III | IHMC22/00039, CP19/00083 |
| Fonds de la Recherche Fondamentale Stratégique-Walloon Excellence in Life Sciences | 40007505, WELBIO-CR-2022A-02 |
| European Commission | CPII21/00013 |
| 'la Caixa' Foundation | LCF/PR/HR19/52160016, 2021-SGR-01320, ID100010434 |
UN SDGs
Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung
-
SDG 3 – Gesundheit und Wohlergehen
Fingerprint
Untersuchen Sie die Forschungsthemen von „Rapid modulation of gut microbiota composition by hypothalamic circuits in mice“. Zusammen bilden sie einen einzigartigen Fingerprint.Zitieren
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver